Neoadjuvant‐modified FOLFIRINOX vs nab‐paclitaxel plus...

  • Main
  • 2020 / 05
  • Neoadjuvant‐modified FOLFIRINOX vs nab‐paclitaxel plus...
Cancer Medicine 2020 / 05

Neoadjuvant‐modified FOLFIRINOX vs nab‐paclitaxel plus gemcitabine for borderline resectable or locally advanced pancreatic cancer patients who achieved surgical resection

Wolfe, Adam R., Prabhakar, Dhivya, Yildiz, Vedat O., Cloyd, Jordan M., Dillhoff, Mary, Abushahin, Laith, Alexandra Diaz, Dayssy, Miller, Eric D., Chen, Wei, Frankel, Wendy L., Noonan, Anne, Williams,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Cancer Medicine
DOI:
10.1002/cam4.3075
Date:
May, 2020
File:
PDF, 624 KB
2020
Conversion to is in progress
Conversion to is failed